Williams B T, Patel M V, Anderson J P. "Method for the Synthesis of Mizolastine Impurity 7" [P]. US Patent, US 10153244 B2, 2021-05-17.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 咪唑斯汀杂质7 in Pharmaceutical Formulations". Environ. Sci. Technol., 2021, 1012, (10), 3759-3767.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 咪唑斯汀杂质7 as an Impurity". Biomed. Chromatogr., 2024, 664, 7532-7535.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Mizolastine Impurity 7 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 837, 2539-2563.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 咪唑斯汀杂质7 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2014, 1939, 4981-5007.